Gabriela A. N. Crespi

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

Luke A. Miles, Gabriela A. N. Crespi, Larissa Doughty et al. · Scientific Reports · 2013 · 133 citations · Full text

Pharmacy, Biochemistry, Pharmacology +17

Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies

Gabriela A. N. Crespi, S.J. Hermans, Michael W. Parker et al. · Scientific Reports · 2015 · 96 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis

Luke A. Miles, S.J. Hermans, Gabriela A. N. Crespi et al. · iScience · 2019 · 83 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +16

Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models

Yvonne Bouter, José Sócrates López‐Noguerola, Petra Tucholla et al. · Acta Neuropathologica · 2015 · 72 citations

Pharmacy, Neurology, Neuroscience +17

Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?

Andrew D. Watt, Gabriela A. N. Crespi, Russell A. Down et al. · Acta Neuropathologica · 2014 · 59 citations · Full text

Pharmacy, Neurology, Neuroscience +14